(NASDAQ: DWTX) Dogwood Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.31%.
Dogwood Therapeutics's earnings in 2025 is -$23,754,108.On average, 2 Wall Street analysts forecast DWTX's earnings for 2025 to be -$7,596,734, with the lowest DWTX earnings forecast at -$16,550,368, and the highest DWTX earnings forecast at $1,356,901. On average, 2 Wall Street analysts forecast DWTX's earnings for 2026 to be -$8,141,405, with the lowest DWTX earnings forecast at -$10,836,096, and the highest DWTX earnings forecast at -$5,446,715.
In 2027, DWTX is forecast to generate -$7,644,512 in earnings, with the lowest earnings forecast at -$8,504,520 and the highest earnings forecast at -$6,784,504.